Dossier
Legislative
introduced
other
doctrine
resolution
introduced
proposed rule
passed chamber
executive action
final rule
enacted
district opinion
circuit opinion
opinion
End Prescription Drug Ads Now Act
Key claim: A House bill would ban advertising of prescription drugs.
Abstract
(HR4605 · 119th Congress) Latest action (2025-07-22): Referred to the House Committee on Energy and Commerce.
Why this matters
A statutory ban on prescription drug advertising would fundamentally reshape how manufacturers reach patients and how consumers learn about branded therapies, affecting a multi-billion-dollar DTC ad market that currently operates under FDA labeling rules rather than a prohibition. At the introduced stage, the bill signals congressional interest but has no immediate effect on what patients see or what drugmakers may promote.